James Sigler, VP of Business Operations at Air Systems Technologies, Inc. Sigler has over 22 years of management experience, including 17 years in the development, manufacturing, and quality management of biological, cell therapy, and small molecule products.
Prior to joining AST, Sigler was Vice President, Manufacturing, at RenaMed Biologics, Inc.; prior to that he was Vice President, Operations and Clinical Supply for Acceleron Pharma, Inc. Sigler was also Vice President, Manufacturing for Curis, Inc., and he was divisional head of manufacturing when Genzyme Corporation sought and received regulatory approval for Carticel, an autologous cell therapy product. He also spent five years on active duty in the U.S. Navy, serving as a nuclear propulsion-trained officer on board USS Enterprise.
James Sigler recieved his undergraduate degree from Cornell University and his MBA degree from Harvard Business School.
It's a pretty common exit strategy to take the company public that allows the original investors or the mezzanine investors to exit but people sometimes forget how much that changes the company just from even... so when you're small or even a medium sized biotech rather than a large business, the pr...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
